Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867539 · ClinicalTrials.gov registry record · Phase 4
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
A Phase 4 study of Carpal Tunnel Syndrome, sponsored by Kettering Health Network.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT03867539 is a Phase 4 study of Carpal Tunnel Syndrome that is actively recruiting participants, run by Kettering Health Network. The registered enrollment target is 64 participants, below the 220-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03867539, a Phase 4 study of Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by Kettering Health Network.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Conditions Studied
Interventions
- OTHER Differing pain management strategy
Study Locations (2)
Ohio
- Orthopedic Associates of Southwest Ohio - Dayton
- Orthopedic Associates of Southwest Ohio - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03867539
The ClinicalTrials.gov registry entry for NCT03867539 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 220-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (71% lower). The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Differing pain management strategy is the first listed.
NCT03867539 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03867539 about?
NCT03867539 is a clinical study titled "Exparel and Education to Avoid Opioids After Carpal Tunnel Release". This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, an...
What is the current status of trial NCT03867539?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2019-02-15. Estimated completion is 2025-03-31.
What conditions does trial NCT03867539 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT03867539?
The interventions under investigation include: Differing pain management strategy (OTHER).
Who is sponsoring clinical trial NCT03867539?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03867539 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Antibiotics for Carpal Tunnel Release Surgery
COMPLETED · Phase 4
-
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
COMPLETED · Phase 4
-
Carpal Arch Space Augmentation (CASA) Clinical Trial
RECRUITING · NA
-
Ultrasound Analysis of Human Carpal Tunnel System
RECRUITING
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.